PK

Pandian Karthik

Active Director Director DIN 09240408
DIN 09240408 First appointment Jul 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Jul 2021
Shareholding value •••• Premium profile

About Pandian Karthik

Data last updated:

Pandian Karthik is a Director at Guduvanchery Medic Centre Private Limited (since 2021), Additional Director at Guduvanchery Pharmacy Private Limited (since 2025) and Director at Deepam Eye Hospital Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Healthcare and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹26.34 Cr; the largest is Guduvanchery Medic Centre Private Limited at ₹13.88 Cr (FY 2025). Earlier, Pandian Karthik was a Designated Partner at Prointellence Confederates Llp (2021–2023).

DIN 09240408
Primary Designation Director
Industry Healthcare
First Appointment 14 Jul 2021
Oldest Company Age 5 yrs
Largest company Guduvanchery Medic Centre Private Limited · ₹13.88 Cr (FY 2025)
Combined revenue ₹26.34 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Jul 20212021₹13.88 Cr (FY 2025)Active
Additional Director25 Nov 20252022₹6.81 Cr (FY 2025)Active
Deepam Eye Hospital Private Limited U85110TN2021PTC146515
Director26 Sep 20212021₹5.64 Cr (FY 2025)Active
Xpressdent Private Limited U86202TN2025PTC187508
Director19 Dec 20252025Active
Additional Director20 May 20222021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner23 Sep 20212021Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Guduvanchery Medic Centre Private Limited
Kudanthai Medical Centre Private Limited
Deepam Eye Hospital Private Limited
Xpressdent Private Limited
Premium access

Shareholding and investment profile for Pandian Karthik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pandian Karthik

Pandian Karthik currently holds 5 directorships: Guduvanchery Medic Centre Private Limited (Director, since 14 Jul 2021, revenue ₹13.88 Cr (FY 2025)); Guduvanchery Pharmacy Private Limited (Additional Director, since 25 Nov 2025, revenue ₹6.81 Cr (FY 2025)); Deepam Eye Hospital Private Limited (Director, since 26 Sep 2021, revenue ₹5.64 Cr (FY 2025)); Xpressdent Private Limited (Director, since 19 Dec 2025); Kudanthai Medical Centre Private Limited (Additional Director, since 20 May 2022).

Pandian Karthik was first appointed on 14 Jul 2021 as Director at Guduvanchery Medic Centre Private Limited. The most recent appointment on record is 19 Dec 2025 at Xpressdent Private Limited.

The 3 current companies of Pandian Karthik that report revenue have a combined latest revenue of ₹26.34 Cr: Guduvanchery Medic Centre Private Limited ₹13.88 Cr (FY 2025); Guduvanchery Pharmacy Private Limited ₹6.81 Cr (FY 2025); Deepam Eye Hospital Private Limited ₹5.64 Cr (FY 2025).

Pandian Karthik held 1 earlier board appointment: Prointellence Confederates Llp (Designated Partner, 23 Sep 2021 to 20 Dec 2023).

The current boards of Pandian Karthik's companies include Padma Sushma (Guduvanchery Medic Centre Private Limited), Mir Altaf Hussain Mir Ali Reza (Xpressdent Private Limited), Regupathy (Kudanthai Medical Centre Private Limited), Selvaraj Abirami (Kudanthai Medical Centre Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available